Brain test may reveal best Alzheimer's drug candidates
NCT ID NCT03703856
Summary
This study aims to find a brain test that can predict which Alzheimer's patients will respond best to the medication memantine. Researchers will measure brain activity after a test dose in 53 patients with mild-to-moderate Alzheimer's. The goal is to match patients with the treatment most likely to help their memory and thinking symptoms over six months.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ALZHEIMER DISEASE are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Clinical Teaching Facility (CTF-B102) at UCSD Medical Center
San Diego, California, 92103, United States
Conditions
Explore the condition pages connected to this study.